The decentralized finance protocol has publicly identified wallets linked to a weekend exploit, warning of criminal and civil action if funds are not returned within 72 hours, as security firms point to a critical validation flaw.
Amidst a patchy economic recovery, European small-cap stocks are back in focus. A surge in insider buying activity points to potential undervaluation in select names across property, cybersecurity, and defense tech sectors.
While the UK kitchenware retailer maintains sales growth, a five-year decline in a key profitability metric and rising liabilities signal potential headwinds for investors.
Despite an 11% share price decline, Fielmann Group AG's robust Return on Equity and solid financials suggest the market may be overlooking its long-term potential, analysts say.
While 'story stocks' captivate with promise, Begbies Traynor Group (LON:BEG) is drawing a different kind of investor attention. The UK-based business recovery and insolvency specialist is showcasing strong earnings growth, expanding margins, and significant insider investment, positioning it as a notable contender in the current market landscape.
JPMorgan Chase confronts heightened regulatory and political pressure as a lawsuit from former President Donald Trump alleges biased account closures, while CEO Jamie Dimon's public spat with Coinbase underscores the intensifying battle between traditional banks and crypto platforms for customer funds.
HSBC Holdings is aggressively rebuilding its investment banking operations in Hong Kong and key Asian hubs, reallocating senior talent and capital to capture growth in IPOs and capital markets, as its strategic focus shifts decisively eastward.
As global investment in artificial intelligence infrastructure accelerates, a handful of semiconductor giants stand to reap outsized rewards. We examine the foundational players whose technology is enabling this historic build-out.
As Bitcoin tumbled below $80,000, a stark divergence emerged: options markets flashed warning signs while prediction contracts remained oddly calm, exposing a fundamental clash in how crypto markets price risk.
The CrossCurve decentralized finance protocol has suffered a $3 million exploit through a vulnerability in its cross-chain bridge, contributing to a devastating start to 2026 that has seen nearly $400 million stolen from the crypto sector.
After a challenging transitional year in 2025, Navitas Semiconductor's pivot towards high-margin data center and industrial markets is expected to accelerate growth and deliver investor returns by 2026, despite near-term revenue pressures.
As regional markets navigate post-oil volatility and geopolitical shifts, a closer look reveals three penny stocks—from Turkish media to Saudi healthcare—that combine resilient balance sheets with high-risk, high-reward potential for the discerning investor.
A renewed emphasis by President Xi Jinping on building a 'strong financial nation' with a globally powerful currency is being interpreted as a signal for accelerated yuan internationalization, as global confidence in the dollar shows signs of strain.
Asian markets opened cautiously Monday as a historic metals sell-off reverberated across asset classes. Bitcoin slipped toward $75,000, while regional equities mostly fell. Investors brace for a critical week packed with corporate earnings, central bank decisions, and key economic data.
President Trump's anticipated nomination of former Fed Governor Kevin Warsh, a vocal critic of the central bank's post-crisis asset purchases, is shifting market focus from interest rates to the future of the Fed's $6.6 trillion balance sheet and its fundamental role in financial markets.
Precious metals markets experienced one of their most volatile weeks on record, with silver plummeting 26% and gold dropping 9% in a dramatic reversal. The sell-off, triggered by shifting U.S. policy expectations, laid bare the market's recent dependence on speculative flows from China, raising questions about stability ahead of the Lunar New Year.
Mueller Industries' stock has soared roughly 700% over the past five years, leaving investors to question if the capital goods standout still holds value. With shares trading near $136, we analyze its valuation through cash flow models and peer comparisons to gauge the path ahead.
BeOne Medicines (NasdaqGS: ONC) has significantly expanded its strategic partnership with systems biology firm InSysBio. The deepened collaboration aims to leverage advanced mechanistic modeling to de-risk clinical trial design, with a particular focus on optimizing dosing and preempting safety challenges like cytokine release syndrome in oncology studies.
As Skyworks Solutions prepares to report Q4 earnings, investors are weighing its track record of beating estimates against a backdrop of expected revenue decline and mixed semiconductor sector performance.
A federal judge has ordered the release of a five-year-old boy and his father from immigration detention, sparking a public clash between Trump administration officials and Democratic lawmakers over the family's asylum status and the treatment of migrant children.
